Song Bijia, Li Wenjing, Wan Lei, Zhang Ling
Beijing Friendship Hospital of Capital Medical University, Beijing, China.
OASIS International Hospital, Beijing, China.
Obes Surg. 2025 Jun 25. doi: 10.1007/s11695-025-08008-y.
Opioids are commonly used in general anesthesia for pain management. However, they are related to obvious side effects. Patients with obesity undergoing laparoscopic sleeve gastrectomy are at higher risk of experiencing adverse effects associated with opioids. However, there is great heterogeneity in how to select and combine antinociceptive drugs to replace opioids. This randomized controlled double-blind study was conducted to evaluate the use effect of opioid-free anesthesia (OFA) in obese patients undergoing laparoscopic sleeve gastrectomy on the quality of postoperative recovery.
This prospective, parallel-group, double-blind, randomized controlled study included seventy-six patients undergoing laparoscopic sleeve gastrectomy in Beijing Friendship Hospital, Capital Medical University. Patients were randomly assigned to OFA group or opioid-based anesthesia (OBA) group. The primary outcome included the 15-item recovery quality scale (QOR-15). Secondary measures included intraoperative hemodynamic stability, intraoperative operation information, duration of until postoperative PACU Aldrete score > 9 points, anesthesia-related complication, and number of analgesic pump presses.
The scores of QOR-15 in OFA group were higher than that in OBA group at 24 h and 48 h after surgery. The total dose of propofol required in OFA group was statistically less than that in OBA group. Patients in the OBA group had significantly lower bispectral index (BIS) values and lower levels of MAP at T2 (after intubation) than those in the OFA group patients in the OBA group. Patients in the OFA group showed significantly lower levels of heart rate (HR) at T3 (after abdominal closure) when compared to the OBA group. The changing trend of visual analog scale (VAS) and OBAS scores recorded after surgery were similar between both groups and the VAS and Overall Benefit of Analgesia Scale (OBAS) scores in OBA group were obviously higher than those in OFA group in each time point. The Rhodes Index of Nausea and Vomiting in OBA group were obviously higher than those in OFA group in each time point.
OFA significantly improved postoperative recovery quality as evidenced by higher QOR-15 scores, reduced postoperative nausea and vomiting (PONV), lower pain scores and decreased opioid requirements compared to OBA. Although duration of awakening from anesthesia was prolonged, OFA demonstrated superior recovery outcomes and fewer complications supporting its clinical utility in obese patients undergoing laparoscopic sleeve gastrectomy.
阿片类药物常用于全身麻醉以进行疼痛管理。然而,它们会带来明显的副作用。接受腹腔镜袖状胃切除术的肥胖患者出现与阿片类药物相关不良反应的风险更高。然而,在如何选择和联合使用抗伤害性药物来替代阿片类药物方面存在很大的异质性。本随机对照双盲研究旨在评估无阿片类药物麻醉(OFA)在接受腹腔镜袖状胃切除术的肥胖患者中对术后恢复质量的使用效果。
这项前瞻性、平行组、双盲、随机对照研究纳入了首都医科大学附属北京友谊医院76例接受腹腔镜袖状胃切除术的患者。患者被随机分配至OFA组或基于阿片类药物的麻醉(OBA)组。主要结局包括包含15个条目的恢复质量量表(QOR - 15)。次要指标包括术中血流动力学稳定性、术中手术信息、术后麻醉后监护治疗病房(PACU)Aldrete评分>9分的持续时间、麻醉相关并发症以及镇痛泵按压次数。
术后24小时和48小时,OFA组的QOR - 15评分高于OBA组。OFA组所需丙泊酚的总剂量在统计学上低于OBA组。OBA组患者在T2(插管后)时的脑电双频指数(BIS)值和平均动脉压(MAP)水平显著低于OFA组患者。与OBA组相比,OFA组患者在T3(关腹后)时心率(HR)水平显著更低。两组术后记录的视觉模拟评分(VAS)和术后镇痛总体效益量表(OBAS)评分的变化趋势相似,且在每个时间点OBA组的VAS和OBAS评分均明显高于OFA组。OBA组在每个时间点的恶心呕吐罗兹指数均明显高于OFA组。
与OBA相比,OFA显著提高了术后恢复质量,表现为QOR - 15评分更高、术后恶心呕吐(PONV)减少、疼痛评分更低以及阿片类药物需求减少。尽管麻醉苏醒时间延长,但OFA显示出更好的恢复结局和更少的并发症,支持其在接受腹腔镜袖状胃切除术的肥胖患者中的临床应用。